2023, Number 1
Epidemiologic clinical study of the endogenous endoftalmitis in Villa Clara
Language: Spanish
References: 21
Page: 27-35
PDF size: 400.29 Kb.
ABSTRACT
Introduction: endogenous endophthalmitis is not frequent but a severe form of ocular inflammation. The source of pathogens is located inside the body, and infection spreads hematogenously.Objective: to determine the clinical behavior and endogenous endophthalmitis frequency.
Methods: a cross-sectional descriptive observational study. Universe understood by 57 eyes with endophthalmitis, 12 of them with endogenous endophthalmitis in Arnaldo Milián Castro Hospital from January 2015 to December 2021.
Results: the endogenous endophthalmitis represented 21.1% among all endophthalmitis cases. Male gender prevailed; mean age was 68.3 years. 58.3% of patients had best corrected visual acuity of movement of hands at diagnosis. The 58.3% and 33.3% presented diabetes and renal chronic illness respectively. The most common infection sources were catheter infections and pneumonia. The causative agents were predominantly gram positive bacteria and the most common specie was Staphylococcus aureus (33.3%). The control infection was achieved in 10 patients, while the great majority had same or worse best corrected visual acuity at infection resolution than the initial.
Conclusions: globally, the proportion of endogenous endophthalmitis among all the cases of endophthalmitis shows a tendency toward the increment in the last years. It is presented with poor visual acuity and the more common infection source was catheter infections. The most common isolated specie was Staphylococcus aureus.
REFERENCES
Mayer C, Loos D, Feucht N, Zapp D, Prahs PM, Tandogan T, et al. Endogenous Endophthalmitis: Epidemiology, Clinic, Therapy and Visual Outcome. Klin Monbl Augenheilkd [Internet]. 2019 [citado 27/05/2022];236(10):1208-1214. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29642263/3. . https://doi.org/10.1055/s-0044-101152
Ishikawa H, Uchida K, Takesue Y, Mori J, Kinoshita T, Morikawa S, et al. Clinical Characteristics and Outcomes in 314 Japanese Patients with Bacterial Endophthalmitis: A Multicenter Cohort Study from J-CREST. Pathogens [Internet]. 2021 [citado 27/05/2022];10:390. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063932/pdf/pathogens-10-00390.pdf4. . https://doi.org/10.3390/pathogens10040390
Gounder PA, Hille DM, Khoo YJ, Phagura RS, Chen FK. Endogenous endophthalmitis in western Australia: A Sixteen-Year Retrospective Study. Retina [Internet]. 2020 [citado 27/05/2022];40(5):908-918. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30893275/5. . https://doi.org/10.1097/iae.0000000000002512
Ting JYL, Teo BH, Khialdin SM, Mushawiahti M. Rapid progression of endogenous endophthalmitis in immunocompromised patients. J Evolution Med Dent Sci [Internet]. 2021 [citado 27/05/2022];10(36):3184-3187. Disponible en: https://www.jemds.com/data_pdf/Safinaz%20Mohd%20Khialdin--issue%2031.pdf6. . https://doi.org/10.14260/jemds/2021/646
Yoshida M, Yokokura S, Nishida T, Mochizuki K, Suzuki T, Maruyama K, et al. Endogenous endophthalmitis caused by group B streptococcus; case reports and review of 35 reported cases. BMC Ophthalmol [Internet]. 2020 [citado 27/05/2022];20(1):126. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110777/7. . https://doi.org/10.1186/s12886-020-01378-0
Spelta S, Di Zazzo A, Antonini M, Bonini S, Coassin M. Does Endogenous Endophthalmitis need a more aggressive treatment? Ocul Immunol Inflamm [Internet]. 2021 [citado 27/05/2022];29(5):937-943. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31951759/8. . https://doi.org/10.1080/09273948.2019.1705497
Danielescu C, Stanca HT, Iorga RE, Darabus DM, Potop V. The Diagnosis and Treatment of Fungal Endophthalmitis: An Update. Diagnostics (Basel) [Internet]. 2022 [citado 27/05/2022];12(3):679. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947249/9. . https://doi.org/10.3390/diagnostics12030679
Regan KA, Radhakrishnan NS, Hammer JD, Wilson BD, Gadkowski LB, Iyer SSR. Endogenous Endophthalmitis: yield of the diagnostic evaluation. BMC Ophthalmol [Internet]. 2020 [citado 27/05/2022];20(1):138. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137237/10. . https://doi.org/10.1186/s12886-020-01418-9
Lourthai P, Choopong P, Dhirachaikulpanich D, Soraprajum K, Pinitpuwadol W, Punyayingyong N, et al. Visual outcome of endogenous endophthalmitis in Thailand. Sci Rep [Internet]. 2021 [citado 27/05/2022];11(1):14313. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275623/11. . https://doi.org/10.1038/s41598-021-93730-7
Muda R, Vayavari V, Subbiah D, Ishak H, Adnan A, Mohamed SO. Endogenous endophthalmitis: a 9-year retrospective study at a tertiary referral hospital in Malaysia. J Ophthalmic Inflamm Infect [Internet]. 2018 [citado 27/05/2022];8(1):14. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179973/12. . https://doi.org/10.1186/s12348-018-0158-3
Gajdzis M, Figula K, Kaminska J, Kaczmarek R. Endogenous Endophthalmitis - The Clinical Significance of the Primary Source of Infection. J Clin Med [Internet]. 2022 [citado 27/05/2022];11(5):1183. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911070/13. . https://doi.org/10.3390/jcm11051183
Tabatabaei SA, Soleimani M, Mirshahi R, Bohrani B, Aminizade M. Culture-proven endogenous endophthalmitis: microbiological and clinical survey. Int Ophthalmol [Internet]. 2020 [citado 27/05/2022];40(12):3521-3528. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32743761/14. . https://doi.org/10.1007/s10792-020-01540-z
Hsieh MC, Chen SN, Cheng CY, Li KH, Chuang CC, Wu JS, et al. Clinicomicrobiological profile, visual outcome and mortality of culture-proven endogenous endophthalmitis in Taiwan. Sci Rep [Internet]. 2020 [citado 27/05/2022];10(1):12481. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385165/15. . https://doi.org/10.1038/s41598-020-69251-0
Luong PM, Tsui E, Batra NN, Zegans ME. Endogenous endophthalmitis and other ocular manifestations of injection drug use. Curr Opin Ophthalmol [Internet]. 2019 [citado 27/05/2022];30(6):506-512. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31589187/16. . https://doi.org/10.1097/icu.0000000000000606
Modjtahedi BS, Finn AP, Barb SM, MacLachlan MJ, van Zyl T, Papakostas TD, et al. Characteristics and Outcomes of Endogenous Endophthalmitis: Eight-Year Experience at a Tertiary Care Center. Ophthalmol Retina [Internet]. 2019 [citado 27/05/2022];3(1):61-72. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30929817/17. . https://doi.org/10.1016/j.oret.2018.08.009
Silpa-Archa S, Ponwong A, Preble JM, Foster CS. Culture-Positive Endogenous Endophthalmitis: An Eleven-Year Retrospective Study in the Central Region of Thailand. Ocul Immunol Inflamm [Internet]. 2018 [citado 27/05/2022];26(4):533-542. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29020471/18. . https://doi.org/10.1080/09273948.2017.1355469
Cho H, Shin YU, Siegel NH, Yu HG, Sobrin L, Patel A, et al. Endogenous Endophthalmitis in the American and Korean Population: An 8-year Retrospective Study. Ocul Immunol Inflamm [Internet]. 2018 [citado 27/05/2022];26(4):496-503. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27459423/19. . https://doi.org/10.1080/09273948.2016.1195000
Celiker H, Kazokoglu H. Ocular culture-proven endogenous endophthalmitis: a 5-year retrospective study of the microorganism spectrum at a tertiary referral center in Turkey. Int Ophthalmol [Internet]. 2019 [citado 27/05/2022];39(8):1743-1751. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30051217/20. . https://doi.org/10.1007/s10792-018-0997-9
Jenkins TL, Talcott KE, Matsunaga DR, Ryan ME, Obeid A, Chung CA, et al. Endogenous Bacterial Endophthalmitis: A Five-Year Retrospective Review at a Tertiary Care Academic Center. Ocul Immunol Inflamm [Internet]. 2020 [citado 27/05/2022];28(6):975-983. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31418616/21. . https://doi.org/10.1080/09273948.2019.1642497